预测IBD是可能的,但我们离实施它有多远?
Williams Turpin1,2, Hamed Kalili3, Jonas Halfvarson4
1Zane Cohen Centre for Digestive Diseases, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada.
Inflammatory bowel diseases
|October 13, 2025
概括
研究人员正在确定炎症性肠道疾病 (IBD) 的早期生物标志物,如克罗恩病和性结肠炎. 这些临床前指标,包括遗传学和蛋白质组学,可以实现IBD的早期检测和预防策略.
科学领域:
- 胃肠道学和免疫学
- 生物标志物发现发现
- 疾病病理生理学病理生理学
背景情况:
- 炎症性肠道疾病 (IBD),包括克罗恩氏病和性结肠炎,是慢性胃肠道疾病,其原因复杂且不完全理解.
- 识别临床前生物标志物对于预测和潜在地预防IBD至关重要.
- 现有的研究探索了各种各样的潜在生物标志物.
研究的目的:
- 审查目前关于IBD临床前生物标志物的研究.
- 讨论这些生物标志物用于早期检测和风险分层的应用.
- 突出个性化IBD预防策略的潜力.
主要方法:
- 审查有关IBD生物标志物的现有文献.
- 对遗传,肠道透性,微生物组,蛋白质组和代谢组数据的分析.
- 讨论整合性风险评分的发展.
主要成果:
- 蛋白质标记物 (例如CXCL9,MMP-10) 和诊断前的代谢变化对IBD有希望.
- 多核数据与人口统计/生活方式因素相结合,可以为个性化风险预测提供信息.
- 挑战包括生物标志物数据的复杂性和可变性.
结论:
- 临床前生物标志物为早期IBD检测和风险分层提供了显著的潜力.
- 综合性方法和验证的预测模型是积极预防IBD的关键.
- 持续的研究和临床试验对于实现早期风险预测的潜力来减少IBD发病率至关重要.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637
Inflammatory Bowel Disease II: Crohn's Disease
952
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
952
Inflammatory Bowel Disease I: Ulcerative Colitis
894
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
894
Inflammatory Bowel Disease IV: Pharmacological Management
517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
517
Inflammatory Bowel Disease V: Surgical Management
450
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
450
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
490
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
490


